Encouraging results for Sightglass Vision’s myopia glasses

Interim data from the first 24 months of a CYPRESS clinical trial suggest that glasses with SightGlass Vision’s Diffusion Optics Technology reduce both axial length and cycloplegic SER progression in six- and seven-year-old children. A paper on the trial – titled “Two Year Effectiveness of a Novel Myopia Management Spectacle ...

To continue reading this article subscribe now

Already an Eyewear Intelligence subscriber? Sign in here.


Become a member today for full access from just €6,70 a week!

Buying a membership today will give you:

  • Unlimited access to ewintelligence.com - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation

To continue reading this article register now.